EUCTR2008-003337-24-IT进行中（未招募）不适用
Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CT - F-18 Fluoro-metil-choline on PET/CT
CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA0 个研究点开始时间: 2012年10月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •locally advanced (previously treated as well) and metastatic prostate cancer istologically proven
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •oAge <30 yrs o >90 yrs
- •o Gleason >8.
- •oPSA <0.2ng/ml
研究者
相似试验
招募中
不适用
Imaging of Metastatic Prostate Cancer Tumors Using 68Ga-NTA-14Cancer - ProstateMetastatic Prostate CancerACTRN12621001704886St. Vincent's Hospital Sydney Limited10
进行中（未招募）
1 期
Imaging of the prostate tumors using PET/CT and PET/MRI with the ligand of the prostatic specific membrane antigene 68Ga-PSMA-11prostatic carcinoma higly suspected or its staging or restagingEUCTR2017-004128-32-CZFakultní nemocnice Plzen200
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trialKCT0004817FutureChem10
已完成
不适用
Novel Imaging in Staging of Primary Prostate CancerHigh Risk Prostate CancerNCT03537391Turku University Hospital80
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancerNeoplasmsKCT0003924Korea Cancer Center Hospital6